Industrial inventions of the 21st century increasingly look less like the creation of fantastic devices and more like the radical optimization of what already exists. In modern business, reducing energy consumption, abandoning bulky structures, and lowering product costs weigh no less than the discovery of new chemical elements.

However, until recently, developers of environmental and energy-saving technologies regularly hit a brick wall of patent bureaucracy. Four key findings of the High Court of Madras (India) in the case of the Danish biotechnology leader Novozymes A/S have completely changed the rules of the game. This legal precedent officially established: if your innovation brings million-dollar savings, it has every right to patent protection, even if it consists of already known engineering parts.

The Essence of the Conflict: Hydrodynamics vs. Giant Mixers

The confrontation flared up around a patent for a device that Novozymes called a “Fermenter equipped with an ejector.” In traditional biotechnological production, huge vats are used to grow beneficial microorganisms, inside of which heavy mechanical stirrers rotate non-stop. They are needed to saturate the solution with oxygen, but they have three huge disadvantages:

• They consume megawatts of expensive electricity;

• They require reinforced metal walls for the tanks;

• They force companies to build separate capital structures with reinforced concrete foundations for the factories.

Novozymes’ engineers offered an elegant alternative: they completely removed the mechanical stirrers. Instead, the liquid was forced to circulate under pressure through an injector system. The mixing process occurred on its own due to the laws of hydrodynamics.

This made it possible to lighten the structure of the tanks, radically reduce electricity costs, and make the equipment so compact that the need for separate buildings disappeared. Despite the obvious benefits, the Patent Office of India blocked the application in 2025, calling the development a “banal engineering choice.”

Four Findings of the Court That Shattered the Bureaucrats’ Logic

Reviewing the company’s appeal, Judge Senthilkumar Ramamoorthy analyzed the patent experts’ decision in detail and recognized their arguments as legally untenable, setting forth new requirements for the evaluation of inventions.

• Independence of the Economic Factor. The Court emphasized that according to the law, an inventive step can be proven either by technical progress or by economic significance. If an invention makes large-scale production significantly cheaper, patent inspectors have no right to ignore this fact. Million-dollar savings are just as much proof of innovation as a new physical part.

• Mechanics is Not Chemistry. The Court explicitly forbade evaluating complex engineering structures according to the strict rules of the medical field. There, pharma giants often cheat: they slightly modify a molecule of an old drug to maintain a monopoly and patent indefinitely. But in mechanics, removing a giant motor and rearranging pipes is not a legal trick, but a real technical breakthrough.

• Prohibition of “Hindsight Bias.” The judge criticized the practice where experts take elements of a new apparatus, find them in several different old patents, and declare: “There is nothing new here.” The Court ruled that an expert must clearly prove exactly what logical impulse would have driven an outside engineer to combine these scattered parts into a single functioning mechanism before this invention came to light.

• An End to Groundless Rejections. The boilerplate phrase of bureaucrats—”this is simply a combination of known devices”—no longer holds legal force unless the expert proves in detail that the parts function in isolation and do not create a new, useful effect together.

Global Outcome for Inventors

The decision of the High Court of Madras became a victory for companies in the fields of green tech, heavy industry, and biotech. It protected developers whose innovations are aimed at process optimization, sustainability, and scalability.

The patent system received a clear signal: 21st-century inventions cannot be evaluated by outdated standards. Companies that spend millions to make the global industry cleaner, more efficient, and more affordable for the consumer now have a reliable legal shield to protect their ideas from copying.

Founder of Research & Patent group Intectica, author of patent algorithms for solving problems in the pharmaceutical industry, patent attorney certified in all intellectual property objects (Patents, Design, TM), with education in chemistry and law, chief expert of the patent institution of Ukraine UKRPATENT (1997-2004). Member of international organizations, including ECTA, PTMG, UAM, lecturer and blogger.